Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Published in: International Journal of Diabetes in Developing Countries 2/2016

01-06-2016 | Editorial

Is body mass index a good indicator of obesity?

Authors: Shriraam Mahadevan, Iftikhar Ali

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2016

Login to get access

Excerpt

The obesity epidemic has become the most blatantly visible public health problem globally. Industrialization, urbanization, and globalizations have resulted in the adoption of pro-obesity lifestyle. The incidence of non-communicable diseases (NCDs) is increasing at alarming rates globally. As of 2014, more than 1.9 billion adults 18 years and older were classified as overweight and more than 600 million as obese. Combined overweight and obesity account for more deaths worldwide than underweight [1‐3]. …
Literature
1.
Zimmet PZ, Alberti KG. Introduction: globalization and the non-communicable disease epidemic. Obesity. 2006;14:1–3.CrossRefPubMed
2.
Nishida C, Uauy R, Kumanyika S, Shetty P. Joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr. 2004;7:245–50.PubMed
3.
4.
‘McNaughton D. “Diabesity” down under: overweight and obesity as cultural signifiers for type 2 diabetes mellitus. Crit Publ Health. 2013;23:274–88.CrossRef
5.
6.
Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes. 2008;32:556–9.CrossRef
7.
Banerji MA, Faridi N, Atluri R, Lebovitz HE, Chaiken RL. Body composition, visceral fat, leptin and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84:137–44.PubMed
8.
Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84:2329–35.PubMed
9.
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRef
10.
Jackson CL, Yeh HC, Szklo M, Hu FB, Wang NY, Dray-Spira R, et al. Body-mass index and all-cause mortality in us adults with and without diabetes. J Gen Intern Med. 2014;29:25–33.CrossRefPubMed
11.
Tobias DK, Pan A, Jackson CL, O’Reilly EJ, Ding EL, Willett WC, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med. 2014;370:233–44.CrossRefPubMedPubMedCentral
12.
Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories. A systematic review and meta-analysis. JAMA. 2013;309:71–82.CrossRefPubMedPubMedCentral
13.
International Union of Nutrition Sciences. The creation of growth standards: a committee report of meeting in Tunis. Am J Clin Nutr. 1971;25:218–20.
14.
Goldstein H, Tanner JM. Ecological considerations in the creation and the use of child growth standards. Lancet. 1980;1:582–5.CrossRefPubMed
15.
Kumaravel V, Shriraam V, Anitharani M, Mahadevan S, Balamurugan AN, Sathiyasekaran B. Are the current Indian growth charts really representative? Analysis of anthropometric assessment of school children in a South Indian district. Indian J Endocr Metab. 2014;18:56–62.CrossRef
16.
Khadilkar V, Yadav S, Agrawal KK, Tamboli S, Banerjee M, Cherian A, et al. Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian children. Indian Pediatr. 2015;52:47–55.CrossRefPubMed
17.
Vanhala M, Vanhala P, Kumpusalo E, Halonen P, Takala J. Relation between obesity from childhood to adulthood and the metabolic syndrome: population based study.BMJ. 1998;317:319.
18.
Srinivasan SR, Myers L, Berenson GS. Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart Study. Hypertension. 2006;48:33–9.CrossRefPubMed
19.
Sinaiko AR, Donahue RP, Jacobs Jr DR, Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. Minneapolis Children’s Blood Press Stud. 1999;99:1471–6.
20.
Twig G, Yaniv G, Levine H, Leiba A, Goldberger N, Derazne E. Body- mass index in 2.3 million adolescents and cardiovascular death in adulthood. N Engl J Med. 2016. doi:10.​1056/​NEJMoa1503840.PubMed
21.
Lloyd LJ, Langley-Evans SC, McMullen S. Childhood obesity and risk of the adult metabolic syndrome: a systematic review. Int J Obes. 2012;36:1–11.CrossRef
Metadata
Title
Is body mass index a good indicator of obesity?
Authors
Shriraam Mahadevan
Iftikhar Ali
Publication date
01-06-2016
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 2/2016
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-016-0506-5

Other articles of this Issue 2/2016

International Journal of Diabetes in Developing Countries 2/2016 Go to the issue

Original Article

Healthcare cost of type 2 diabetes mellitus in Bangladesh: a hospital-based study

Original Article

New cutoff values for fat mass index, fat-free mass index and percent body fat in overweight and obese men living in Riyadh, SA

Original Article

The study of diabetes prevalence and related risk factors in Fuyang, a Chinese county under rapid urbanization

Erratum

Erratum to: Is body mass index a good indicator of obesity?

Editorial Note

Editorial

Original Article

Type 2 diabetes in Bangladesh and associated risk factors
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits